Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Ensuring the Best Use of Data: The Adolescent Brain Cognitive Development Study.

Compton WM, Dowling GJ, Garavan H.

JAMA Pediatr. 2019 Jul 15. doi: 10.1001/jamapediatrics.2019.2081. [Epub ahead of print] No abstract available.

PMID:
31305867
2.

Targeting Youth to Prevent Later Substance Use Disorder: An Underutilized Response to the US Opioid Crisis.

Compton WM, Jones CM, Baldwin GT, Harding FM, Blanco C, Wargo EM.

Am J Public Health. 2019 Jun;109(S3):S185-S189. doi: 10.2105/AJPH.2019.305020.

3.

Self-reported Medical and Nonmedical Cannabis Use Among Pregnant Women in the United States.

Volkow ND, Han B, Compton WM, McCance-Katz EF.

JAMA. 2019 Jun 18. doi: 10.1001/jama.2019.7982. [Epub ahead of print] No abstract available.

PMID:
31211824
4.

Misuse of Immediate-Release Stimulants: Response to Diller.

Compton WM, Han B, Blanco C, Jones CM.

Am J Psychiatry. 2019 Jan 1;176(1):77-78. doi: 10.1176/appi.ajp.2018.18080948r. No abstract available.

PMID:
30848946
5.

Longitudinal e-cigarette and cigarette use among US youth in the PATH Study (2013-2015).

Stanton CA, Bansal-Travers M, Johnson AL, Sharma E, Katz L, Ambrose BK, Silveira ML, Day H, Sargent J, Borek N, Compton WM, Johnson S, Kimmel H, Kaufman AR, Limpert J, Abrams D, Cummings KM, Goniewicz ML, Tanski S, Travers MJ, Hyland AJ, Pearson JL.

J Natl Cancer Inst. 2019 Jan 25. doi: 10.1093/jnci/djz006. [Epub ahead of print]

PMID:
30689915
6.

Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private Insurers.

Heyward J, Jones CM, Compton WM, Lin DH, Losby JL, Murimi IB, Baldwin GT, Ballreich JM, Thomas DA, Bicket MC, Porter L, Tierce JC, Alexander GC.

JAMA Netw Open. 2018 Oct 5;1(6):e183044. doi: 10.1001/jamanetworkopen.2018.3044.

7.

Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers.

Lin DH, Jones CM, Compton WM, Heyward J, Losby JL, Murimi IB, Baldwin GT, Ballreich JM, Thomas DA, Bicket M, Porter L, Tierce JC, Alexander GC.

JAMA Netw Open. 2018 Jun 1;1(2):e180235. doi: 10.1001/jamanetworkopen.2018.0235.

8.

Mental Health Problems and Onset of Tobacco Use Among 12- to 24-Year-Olds in the PATH Study.

Green VR, Conway KP, Silveira ML, Kasza KA, Cohn A, Cummings KM, Stanton CA, Callahan-Lyon P, Slavit W, Sargent JD, Hilmi N, Niaura RS, Reissig CJ, Lambert E, Zandberg I, Brunette MF, Tanski SE, Borek N, Hyland AJ, Compton WM.

J Am Acad Child Adolesc Psychiatry. 2018 Dec;57(12):944-954.e4. doi: 10.1016/j.jaac.2018.06.029. Epub 2018 Oct 4.

PMID:
30522740
9.

Time since first cannabis use and 12-month prevalence of cannabis use disorder among youth and emerging adults in the United States.

Han B, Compton WM, Blanco C, Jones CM.

Addiction. 2019 Apr;114(4):698-707. doi: 10.1111/add.14511. Epub 2018 Dec 21.

PMID:
30474910
10.

Associations of risk factors of e-cigarette and cigarette use and susceptibility to use among baseline PATH study youth participants (2013-2014).

Sawdey MD, Day HR, Coleman B, Gardner LD, Johnson SE, Limpert J, Hammad HT, Goniewicz ML, Abrams DB, Stanton CA, Pearson JL, Kaufman AR, Kimmel HL, Delnevo CD, Compton WM, Bansal-Travers M, Niaura RS, Hyland A, Ambrose BK.

Addict Behav. 2019 Apr;91:51-60. doi: 10.1016/j.addbeh.2018.11.027. Epub 2018 Nov 17.

PMID:
30473246
11.

Correlates of Transitions in Tobacco Product Use by U.S. Adult Tobacco Users between 2013⁻2014 and 2014⁻2015: Findings from the PATH Study Wave 1 and Wave 2.

Kasza KA, Coleman B, Sharma E, Conway KP, Cummings KM, Goniewicz ML, Niaura RS, Lambert EY, Schneller LM, Feirman SP, Donaldson EA, Cheng YC, Murphy I, Pearson JL, Trinidad DR, Bansal-Travers M, Elton-Marshall T, Gundersen DA, Stanton CA, Abrams DB, Fong GT, Borek N, Compton WM, Hyland AJ.

Int J Environ Res Public Health. 2018 Nov 14;15(11). pii: E2556. doi: 10.3390/ijerph15112556.

12.

Transitions in Tobacco Product Use by U.S. Adults between 2013⁻2014 and 2014⁻2015: Findings from the PATH Study Wave 1 and Wave 2.

Kasza KA, Borek N, Conway KP, Goniewicz ML, Stanton CA, Sharma E, Fong GT, Abrams DB, Coleman B, Schneller LM, Lambert EY, Pearson JL, Bansal-Travers M, Murphy I, Cheng YC, Donaldson EA, Feirman SP, Gravely S, Elton-Marshall T, Trinidad DR, Gundersen DA, Niaura RS, Cummings KM, Compton WM, Hyland AJ.

Int J Environ Res Public Health. 2018 Nov 9;15(11). pii: E2515. doi: 10.3390/ijerph15112515.

13.

Prevalence and Correlates of Benzodiazepine Use, Misuse, and Use Disorders Among Adults in the United States.

Blanco C, Han B, Jones CM, Johnson K, Compton WM.

J Clin Psychiatry. 2018 Oct 16;79(6). pii: 18m12174. doi: 10.4088/JCP.18m12174.

PMID:
30403446
14.

Correlates of Prescription Opioid Use, Misuse, Use Disorders, and Motivations for Misuse Among US Adults.

Han B, Compton WM, Blanco C, Jones CM.

J Clin Psychiatry. 2018 Aug 14;79(5). pii: 17m11973. doi: 10.4088/JCP.17m11973.

PMID:
30153405
15.

Prevalence and correlates of HIV testing and HIV-positive status in the US: Results from the National Epidemiological Survey on Alcohol and Related Conditions III (NESARC-III).

Blanco C, Wall MM, Compton WM, Kahana S, Feng T, Saha T, Elliott JC, Hall HI, Grant BF.

J Psychiatr Res. 2018 Oct;105:1-8. doi: 10.1016/j.jpsychires.2018.08.007. Epub 2018 Aug 3.

PMID:
30118996
16.

Longitudinal associations between youth tobacco and substance use in waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study.

Silveira ML, Conway KP, Green VR, Kasza KA, Sargent JD, Borek N, Stanton CA, Cohn A, Hilmi N, Cummings KM, Niaura RS, Lambert EY, Brunette MF, Zandberg I, Tanski SE, Reissig CJ, Callahan-Lyon P, Slavit WI, Hyland AJ, Compton WM.

Drug Alcohol Depend. 2018 Oct 1;191:25-36. doi: 10.1016/j.drugalcdep.2018.06.018. Epub 2018 Jul 25.

PMID:
30077053
17.

Promoting Wellness in Older Adults with Mental Illnesses and Substance Use Disorders: Call to Action to All Stakeholders.

Jeste DV, Peschin S, Buckwalter K, Blazer DG, McGuire MH, Moutier C, Doederlein A, Niederehe G, Altman B, Borenstein J, Saks E, Norquist G, Koob GF, Compton WM, Sperling A, Bain L, Glorioso D, Paul IH, Reynolds CF 3rd.

Am J Geriatr Psychiatry. 2018 Jun;26(6):617-630. doi: 10.1016/j.jagp.2018.03.011. Epub 2018 Apr 26. No abstract available.

18.

Prescription Drug Monitoring Programs: Promising Practices in Need of Refinement.

Compton WM, Wargo EM.

Ann Intern Med. 2018 Jun 5;168(11):826-827. doi: 10.7326/M18-0883. Epub 2018 May 8. No abstract available.

PMID:
29801101
19.

Changes in Synthetic Opioid Involvement in Drug Overdose Deaths in the United States, 2010-2016.

Jones CM, Einstein EB, Compton WM.

JAMA. 2018 May 1;319(17):1819-1821. doi: 10.1001/jama.2018.2844. No abstract available.

20.

Transitions in electronic cigarette use among adults in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1 and 2 (2013-2015).

Coleman B, Rostron B, Johnson SE, Persoskie A, Pearson J, Stanton C, Choi K, Anic G, Goniewicz ML, Cummings KM, Kasza KA, Silveira ML, Delnevo C, Niaura R, Abrams DB, Kimmel HL, Borek N, Compton WM, Hyland A.

Tob Control. 2019 Jan;28(1):50-59. doi: 10.1136/tobaccocontrol-2017-054174. Epub 2018 Apr 25.

21.

Prevalence and Correlates of Prescription Stimulant Use, Misuse, Use Disorders, and Motivations for Misuse Among Adults in the United States.

Compton WM, Han B, Blanco C, Johnson K, Jones CM.

Am J Psychiatry. 2018 Aug 1;175(8):741-755. doi: 10.1176/appi.ajp.2018.17091048. Epub 2018 Apr 16.

PMID:
29656665
22.

Medication development in opioid addiction: Meaningful clinical end points.

Volkow ND, Woodcock J, Compton WM, Throckmorton DC, Skolnick P, Hertz S, Wargo EM.

Sci Transl Med. 2018 Mar 28;10(434). pii: eaan2595. doi: 10.1126/scitranslmed.aan2595. Review.

PMID:
29593105
23.

Trends in and correlates of medical marijuana use among adults in the United States.

Han B, Compton WM, Blanco C, Jones CM.

Drug Alcohol Depend. 2018 May 1;186:120-129. doi: 10.1016/j.drugalcdep.2018.01.022. Epub 2018 Mar 14.

PMID:
29567626
24.

Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults.

Han B, Compton WM, Blanco C, Jones CM.

Ann Intern Med. 2018 Mar 6;168(5):383-384. doi: 10.7326/L17-0700. No abstract available.

PMID:
29507965
25.

What Is an Addictive Disorder?

Blanco C, Compton WM, Lopez MF.

JAMA Psychiatry. 2018 Mar 1;75(3):229-230. doi: 10.1001/jamapsychiatry.2017.4356. No abstract available.

PMID:
29417148
26.

Promising roles for pharmacists in addressing the U.S. opioid crisis.

Compton WM, Jones CM, Stein JB, Wargo EM.

Res Social Adm Pharm. 2019 Aug;15(8):910-916. doi: 10.1016/j.sapharm.2017.12.009. Epub 2017 Dec 31.

PMID:
29325708
27.

National Trends in the Prevalence of Suicidal Ideation and Behavior Among Young Adults and Receipt of Mental Health Care Among Suicidal Young Adults.

Han B, Compton WM, Blanco C, Colpe L, Huang L, McKeon R.

J Am Acad Child Adolesc Psychiatry. 2018 Jan;57(1):20-27.e2. doi: 10.1016/j.jaac.2017.10.013. Epub 2017 Nov 6.

PMID:
29301664
28.

Prescription Opioids for Pain Management in Patients on Dialysis.

Han B, Compton WM.

J Am Soc Nephrol. 2017 Dec;28(12):3432-3434. doi: 10.1681/ASN.2017091041. Epub 2017 Nov 6. No abstract available.

29.

National Trends in and Correlates of Nonmedical Use of Prescription Stimulants, Nonmedical Use Frequency, and Use Disorders.

Han B, Jones CM, Blanco C, Compton WM.

J Clin Psychiatry. 2017 Nov/Dec;78(9):e1250-e1258. doi: 10.4088/JCP.17m11760.

PMID:
29045771
30.

Prevalence, Treatment, And Unmet Treatment Needs Of US Adults With Mental Health And Substance Use Disorders.

Han B, Compton WM, Blanco C, Colpe LJ.

Health Aff (Millwood). 2017 Oct 1;36(10):1739-1747. doi: 10.1377/hlthaff.2017.0584.

PMID:
28971918
31.

From Epidemiology to Interventions and Back.

Blanco C, Compton WM, Weiss SRB.

Am J Psychiatry. 2017 Oct 1;174(10):915-916. doi: 10.1176/appi.ajp.2017.17070796. No abstract available.

PMID:
28965470
32.

Co-occurrence of tobacco product use, substance use, and mental health problems among youth: Findings from wave 1 (2013-2014) of the population assessment of tobacco and health (PATH) study.

Conway KP, Green VR, Kasza KA, Silveira ML, Borek N, Kimmel HL, Sargent JD, Stanton CA, Lambert E, Hilmi N, Reissig CJ, Jackson KJ, Tanski SE, Maklan D, Hyland AJ, Compton WM.

Addict Behav. 2018 Jan;76:208-217. doi: 10.1016/j.addbeh.2017.08.009. Epub 2017 Aug 18.

PMID:
28846942
33.

National Trends in Substance Use and Use Disorders Among Youth.

Han B, Compton WM, Blanco C, DuPont RL.

J Am Acad Child Adolesc Psychiatry. 2017 Sep;56(9):747-754.e3. doi: 10.1016/j.jaac.2017.06.011. Epub 2017 Jul 4.

PMID:
28838579
34.

Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health.

Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM.

Ann Intern Med. 2017 Sep 5;167(5):293-301. doi: 10.7326/M17-0865. Epub 2017 Aug 1.

PMID:
28761945
35.

Cannabis Use and Cannabis Use Disorders Among Youth in the United States, 2002-2014.

Han B, Compton WM, Jones CM, Blanco C.

J Clin Psychiatry. 2017 Nov/Dec;78(9):1404-1413. doi: 10.4088/JCP.16m10948.

PMID:
28686820
36.

Indicators of dependence for different types of tobacco product users: Descriptive findings from Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health (PATH) study.

Strong DR, Pearson J, Ehlke S, Kirchner T, Abrams D, Taylor K, Compton WM, Conway KP, Lambert E, Green VR, Hull LC, Evans SE, Cummings KM, Goniewicz M, Hyland A, Niaura R.

Drug Alcohol Depend. 2017 Sep 1;178:257-266. doi: 10.1016/j.drugalcdep.2017.05.010. Epub 2017 Jun 28.

PMID:
28675817
37.

Electronic cigarette use among US adults in the Population Assessment of Tobacco and Health (PATH) Study, 2013-2014.

Coleman BN, Rostron B, Johnson SE, Ambrose BK, Pearson J, Stanton CA, Wang B, Delnevo C, Bansal-Travers M, Kimmel HL, Goniewicz ML, Niaura R, Abrams D, Conway KP, Borek N, Compton WM, Hyland A.

Tob Control. 2017 Dec;26(e2):e117-e126. doi: 10.1136/tobaccocontrol-2016-053462. Epub 2017 Jun 17.

PMID:
28624763
38.

Co-occurrence of tobacco product use, substance use, and mental health problems among adults: Findings from Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health (PATH) Study.

Conway KP, Green VR, Kasza KA, Silveira ML, Borek N, Kimmel HL, Sargent JD, Stanton C, Lambert E, Hilmi N, Reissig CJ, Jackson KJ, Tanski SE, Maklan D, Hyland AJ, Compton WM.

Drug Alcohol Depend. 2017 Aug 1;177:104-111. doi: 10.1016/j.drugalcdep.2017.03.032. Epub 2017 May 30.

39.

Medical Marijuana Laws and Cannabis Use: Intersections of Health and Policy.

Compton WM, Volkow ND, Lopez MF.

JAMA Psychiatry. 2017 Jun 1;74(6):559-560. doi: 10.1001/jamapsychiatry.2017.0723. No abstract available.

PMID:
28445570
40.

Marijuana Use During Stages of Pregnancy in the United States.

Volkow ND, Han B, Compton WM, Blanco C.

Ann Intern Med. 2017 May 16;166(10):763-764. doi: 10.7326/L17-0067. Epub 2017 Apr 18. No abstract available.

PMID:
28418460
41.

Recent Increases in Cocaine-Related Overdose Deaths and the Role of Opioids.

McCall Jones C, Baldwin GT, Compton WM.

Am J Public Health. 2017 Mar;107(3):430-432. doi: 10.2105/AJPH.2016.303627.

42.

Tobacco-Product Use by Adults and Youths in the United States in 2013 and 2014.

Kasza KA, Ambrose BK, Conway KP, Borek N, Taylor K, Goniewicz ML, Cummings KM, Sharma E, Pearson JL, Green VR, Kaufman AR, Bansal-Travers M, Travers MJ, Kwan J, Tworek C, Cheng YC, Yang L, Pharris-Ciurej N, van Bemmel DM, Backinger CL, Compton WM, Hyland AJ.

N Engl J Med. 2017 Jan 26;376(4):342-353. doi: 10.1056/NEJMsa1607538. Erratum in: N Engl J Med. 2018 Feb 1;378(5):492.

43.

Use of Marijuana for Medical Purposes Among Adults in the United States.

Compton WM, Han B, Hughes A, Jones CM, Blanco C.

JAMA. 2017 Jan 10;317(2):209-211. doi: 10.1001/jama.2016.18900. No abstract available.

PMID:
27992636
44.

The Risks of Marijuana Use During Pregnancy.

Volkow ND, Compton WM, Wargo EM.

JAMA. 2017 Jan 10;317(2):129-130. doi: 10.1001/jama.2016.18612. No abstract available. Erratum in: JAMA. 2017 Apr 11;317(14 ):1482.

PMID:
27992628
45.

Epidemiology of DSM-5 bipolar I disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III.

Blanco C, Compton WM, Saha TD, Goldstein BI, Ruan WJ, Huang B, Grant BF.

J Psychiatr Res. 2017 Jan;84:310-317. doi: 10.1016/j.jpsychires.2016.10.003. Epub 2016 Oct 7.

PMID:
27814503
46.

Complexities in understanding and addressing the serious public health issues related to the nonmedical use of prescription drugs.

Arria AM, Compton WM.

Addict Behav. 2017 Feb;65:215-217. doi: 10.1016/j.addbeh.2016.09.002. Epub 2016 Sep 9. No abstract available.

47.

Trends in Receipt of Mental Health Treatments Among Adults in the United States, 2008-2013.

Han B, Compton WM, Mojtabai R, Colpe L, Hughes A.

J Clin Psychiatry. 2016 Oct;77(10):1365-1371. doi: 10.4088/JCP.15m09982.

PMID:
27486895
48.

Toward Precision Epidemiology.

Blanco C, Compton WM, Grant BF.

JAMA Psychiatry. 2016 Oct 1;73(10):1008-1009. doi: 10.1001/jamapsychiatry.2016.1869. No abstract available.

PMID:
27603943
49.

Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys.

Compton WM, Han B, Jones CM, Blanco C, Hughes A.

Lancet Psychiatry. 2016 Oct;3(10):954-964. doi: 10.1016/S2215-0366(16)30208-5. Epub 2016 Aug 31.

PMID:
27592339
50.

Design and methods of the Population Assessment of Tobacco and Health (PATH) Study.

Hyland A, Ambrose BK, Conway KP, Borek N, Lambert E, Carusi C, Taylor K, Crosse S, Fong GT, Cummings KM, Abrams D, Pierce JP, Sargent J, Messer K, Bansal-Travers M, Niaura R, Vallone D, Hammond D, Hilmi N, Kwan J, Piesse A, Kalton G, Lohr S, Pharris-Ciurej N, Castleman V, Green VR, Tessman G, Kaufman A, Lawrence C, van Bemmel DM, Kimmel HL, Blount B, Yang L, O'Brien B, Tworek C, Alberding D, Hull LC, Cheng YC, Maklan D, Backinger CL, Compton WM.

Tob Control. 2017 Jul;26(4):371-378. doi: 10.1136/tobaccocontrol-2016-052934. Epub 2016 Aug 8.

Supplemental Content

Loading ...
Support Center